The preliminary data was accepted as a late breaking abstract.
If it did not include efficacy results the scientific world needs to know about, it would not fulfil the criteria in this category.
All current study arms in the DIPG combo PNOC trial include paxalisib and ONC201 in different treatment patterns.
- Forums
- ASX - By Stock
- KZA
- Ann: Presentations at upcoming scientific meetings
Ann: Presentations at upcoming scientific meetings, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)